Senator questions CVS, Walgreens about growth in 340B participation

Sen. Bill Cas­sidy (R-LA), a rank­ing mem­ber on the Health, Ed­u­ca­tion, La­bor and Pen­sions Com­mit­tee, re­quest­ed in­for­ma­tion from CVS Health and Wal­greens Boots Al­liance about their roles as the largest phar­ma­cy par­tic­i­pants in the fed­er­al gov­ern­ment’s 340B pro­gram, which pro­vides out­pa­tient drugs at a dis­count to low-in­come pa­tients.

CVS is the largest con­tract phar­ma­cy par­tic­i­pant in the 340B pro­gram, ac­cord­ing to Cas­sidy’s let­ter, with Wal­greens fol­low­ing close­ly be­hind.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.